Association between Clinical Frailty Scale and mortality 24 months after hospitalisation in adult patients with COVID-19

Autor: Julia Minnema, Melvin Lafeber, Roos S.G. Sablerolles, Janneke A.L. van Kempen, Lisanne Tap, Harmke A. Polinder-Bos, Bob P.A. van de Loo, Hugo van der Kuy, Miriam C. Faes, Jacomien Aleman, Jos Tournoy, Lorenz Van der Linden, Marco Gambera, Isabella Martignoni, Ronald Van Etten, Hein van Onzenoort, Mariette Kappers, Peter van Wijngaarden, Jose Verstijnen, Vera Theeuwes, Marleen Kemper, Elise Slob, Ferdi Sombogaard, Heshu Abdullah-Koolmees, Roland van den Berg, Hugo de Wit, Betul Dilek, Freija Hogenhuis, Vahid Buyukayten, Britt te Brake, Margriet Nieuwenhuijzen, Maria Scheeren, Madelief de Wit, Arjan Bulsink, Ingrid van Haelst, Peter ter Horst, Rosalie Moorlag, Anja Vos, Annemiek Otten-Helmers, Erik van Kan, Marije Voskamp, Marieke Ebbens, Marieke Ezinga, Cees van Nieuwkoop, Loes Visser, Caroline Ghazarian, Doranne Hilarius, Gonneke Hermanides, Carlinda Bresser, Judith Derijks-Engwegen, Ebbie Boemaars, Zahira Getrouw, Barbara Maat, Peter Wierenga, Tessa Bosch, Lisanne Krens, Kajie Liang, Langeza Saleh, Milou van Heuckelum, Linda Hendriksen, Paul van der Linden, Kaylen Guda, Kristel Crommentuijn, Ilse Cornelissen-Wesseling, Jeroen Diepstraten, Jacobien Ellerbroek, Saskia Coenradie, Debbie Deben, Kim Hurkens, Dennis Wong, Marion Vromen, Marjolein de Bock, Suzan Savelkoul, Saskia Wolters, Louise Andrews, Eefje Jong, Rosanne Kranenburg, Joana Soares, Fatima Falcao, Mariana Solano, Erica Viegas, Margarida Falcao, Helena Farinha, Dina Mendes, Joao Rijo, Marta Miarons, Maria Queralt Gorgas, Cristina García Yubero, Laura Portillo Horcajada, Kim Keijzers, Silke Lim, Linden Ashfield, Helen Bell, Naomi Fitzhugh, Glenda Fleming, Nicola Goodfellow, Joanne Hanley, Michael Scott, Simon P. Mooijaart, Jacobijn Gussekloo, Petra Elders, Geeske Peeters

Publikováno v: Heliyon, Vol 10, Iss 23, Pp e40456- (2024)

Background: The clinical frailty scale (CFS) was used as a triage tool for medical decision making during the COVID-19 pandemic. The CFS has been posed as a suitable risk marker for in-hospital mortality in COVID-19 patients. We evaluated whether the

Externí odkaz: https://doaj.org/article/c6e84359db6c419a80d153ef70cdacce

The Real-World Study of Immunogenicity and Safety of the Adjuvant Recombinant Vaccine against Varicella Zoster Virus in Patients with Immune-Mediated Inflammatory Diseases Treated with Janus Kinase Inhibitors

Autor: Ana Esteban-Vazquez, Martina Steiner, Elisabet Castañeda, Cristina Andreu-Vazquez, Israel J. Thiussard, Angela Somodevilla, Moisés Gracia-Martínez, Rosa Sánchez-Diaz, Cristina García-Yubero, Maria Beatriz Paredes-Romero, Santiago Munoz-Fernández

Publikováno v: Vaccines, Vol 11, Iss 10, p 1610 (2023)

Background. The risk of herpes zoster reactivation is increased in immunocompromised patients, especially in those with immune-mediated inflammatory diseases (IMIDs) on Janus kinase inhibitor (JAKi) treatment. The recombinant subunit herpes zoster va

Externí odkaz: https://doaj.org/article/6f51cbb61a8445348f65f9a4224d22b0

Use of Generic Antiretroviral Drugs and Single-Tablet Regimen De-Simplification for the Treatment of HIV Infection in Spain

Autor: Marta, Ruiz-Algueró, Belén, Alejos, Cristina, García Yubero, Melchor, Riera Jaume, José, Antonio Iribarren, Víctor, Asensi, Francisco, Pasquau, Carlos E, Galera, Mario, Pascual-Carrasco, Adolfo, Muñoz, Inmaculada, Jarrín, Inés, Suárez-García, Juan A, Pineda

Publikováno v: AIDS research and human retroviruses. 38(6)

The present study sought to describe the use of generic drugs and single-tablet regimen (STR) de-simplification for the treatment of human immunodeficiency virus (HIV) infection among 41 hospitals from the cohort of the Spanish HIV/AIDS Research Netw

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0c488836635366fc7cf357eb345484f
https://pubmed.ncbi.nlm.nih.gov/35357907

Incidence of COVID-19 in 902 Patients With Immunomediated Inflammatory Diseases Treated With Biologics and Targeted Synthetic Disease-Modifying Antirheumatic Drugs-Findings From the BIOCOVID Study

Autor: Martina Steiner, Ana Victoria Esteban, Cristina García-Yubero, Santiago Muñoz-Fernández, Alejandro Gómez Gómez, Noemí Manceñido, Teresa Navío, Maria Angeles Matías, Tatiana Cobo-Ibáñez, Laura Cebrian, Israel Thuissard, Liz Romero, Cristina Andreu, Mar Esteban, Fernando Sánchez, Concepción Esteban, María Rosario Arribas, R. Pajares, Alicia Martínez

Publikováno v: Journal of clinical rheumatology : practical reports on rheumaticmusculoskeletal diseases. 28(2)

OBJECTIVES: The aim of this study was to examine the incidence of coronavirus disease 2019 (COVID-19) among patients with immunomediated inflammatory diseases (IMIDs) treated with biologic or targeted synthetic disease-modifying antirheumatic drugs (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed88a57852c48e57a3736974cd027f24
https://pubmed.ncbi.nlm.nih.gov/33657593

The Real-World Study of Immunogenicity and Safety of the Adjuvant Recombinant Vaccine against Varicella Zoster Virus in Patients with Immune-Mediated Inflammatory Diseases Treated with Janus Kinase Inhibitors.

Autor: Esteban-Vazquez, Ana, Steiner, Martina, Castañeda, Elisabet, Andreu-Vazquez, Cristina, Thiussard, Israel J., Somodevilla, Angela, Gracia-Martínez, Moisés, Sánchez-Diaz, Rosa, García-Yubero, Cristina, Paredes-Romero, Maria Beatriz, Munoz-Fernández, Santiago

Publikováno v: Vaccines; Oct2023, Vol. 11 Issue 10, p1610, 9p